Glucose conjugation for the specific targeting and treatment of cancer
Open accessThe DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Cancers of diverse origins exhibit marked glucose avidity and high rates of aerobic glycolysis. Increased understanding of this dysfunctional metabolism known as the Warburg effect has led to an interest in targeting it for cancer therapy. One promising strategy for such targeting is glycoconjugation, the linking of a drug to glucose or another sugar. This review summarizes the most salient examples of glycoconjugates, in which known cytotoxins or targeted anticancer therapeutics have been linked to glucose (or another glucose transporter substrate sugar) for improved cancer targeting and selectivity. Building on these examples, this review also provides a series of guidelines for the design and mechanistic evaluation of future glycoconjugates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 1×
“Today this phenomenon is known as the Warburg effect and is recognized as one of the hallmarks of cancer [3].”
BackgroundWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 1×
“Almost a century ago, the German scientist Otto Warburg observed that cancerous tissues consume large amounts of glucose compared to non-transformed tissue and have high rates of aerobic glycolysis [1, 2].”
BackgroundThe metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416 · cited 1×
“Almost a century ago, the German scientist Otto Warburg observed that cancerous tissues consume large amounts of glucose compared to non-transformed tissue and have high rates of aerobic glycolysis [1, 2].”
BackgroundTrastuzumab emtansine for HER2-positive advanced breast cancer
Verma, S., Miles, D., Gianni, L., Krop, I. E., Welslau, M., Baselga, J., Pegram, M., Oh, D.-Y., Diéras, V., Guardino, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1209124 · Cited by 3,834 · cited 1×
“Another antibody-drug conjugate, Kadcyla (trastuzumab emtansine; Figure 2b), received US FDA approval in February 2013 for the treatment of HER2-positive breast cancer following the EMILIA clinical trial [15].”
BackgroundTargeting cancer metabolism: a therapeutic window opens
Vander Heiden, M. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3504 · Cited by 1,411 · cited 1×
“Most efforts have focused on using small molecules to inhibit the function of metabolic enzymes, as comprehensively reviewed elsewhere [10, 11].”
BackgroundParker, N., Turk, M. J., Westrick, E., Lewis, J. D., Low, P. S., & Leamon, C. P. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2004.12.026 · Cited by 1,197 · cited 1×
“For this reason, folate receptor α (FR-α) is overexpressed in an estimated 40% of human cancers (it is expressed only by certain types of epithelial cells in healthy individuals) [17, 18].”
BackgroundDe Vivo, D. C., Trifiletti, R. R., Jacobson, R. I., Ronen, G. M., Behmand, R. A., & Harik, S. I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109053251006 · Cited by 800 · cited 1×
“Incidentally, humans born with a mutated, functionallyimpaired GLUT-1 transporter experience a severe phenotype known as De Vivo disease which results in mental retardation, seizures, and a host of neurological deficits, underscoring the importance of GLUT-1 in supplying glucose to the nervous system [95].”
BackgroundSenter, P. D., & Sievers, E. L. (2012) · Nature Biotechnology · doi:10.1038/nbt.2289 · Cited by 763 · cited 1×
“Adcertis is thought to enter cancer cells via CD30 receptor-mediated endocytosis and subsequently be trafficked to endosomes, where a combination of degradative enzymes and increased acidity lead to cleavage to the active tubulin inhibitor [14].”
BackgroundGenes of glycolysis are ubiquitously overexpressed in 24 cancer classes
Altenberg, B., & Greulich, K. O. (2004) · Genomics · doi:10.1016/j.ygeno.2004.08.010 · Cited by 659 · cited 1×
“Glycolytic enzymes, as well as the insulinindependent glucose transporter GLUT-1, are widely overexpressed in human cancers [4, 5], and high expression levels of these proteins in tumor biopsy samples correlate with poor cancer prognosis, making them attractive therapeutic targets [6–9].”
BackgroundFolate-targeted therapeutic and imaging agents for cancer
Low, P. S., & Kularatne, S. A. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.03.022 · Cited by 585 · cited 1×
“For this reason, folate receptor α (FR-α) is overexpressed in an estimated 40% of human cancers (it is expressed only by certain types of epithelial cells in healthy individuals) [17, 18].”
Background
Cited by
Items 201–300 of 401
Wang, Y., Shen, X., Su, F., Xie, Y.-R., Wang, L., Zhang, N., Wu, Y.-L., Niu, Y., Zhang, D., Zi, C., et al. (2021) · Molecules · doi:10.3390/molecules26144361 · Cited by 14
Rachmale, M., Rajput, N., Jadav, T., Sahu, A. K., Tekade, R. K., & Sengupta, P. (2022) · Drug Metabolism Reviews · doi:10.1080/03602532.2022.2048007 · Cited by 13
“This conjugate dissociates to give the free drug at the target site thus increasing selectivity for cancer cells and reducing toxicity for normal cells (Calvaresi and Hergenrother 2013).”
BackgroundThe chemomodulatory effects of glufosfamide on docetaxel cytotoxicity in prostate cancer cells
Attia, R. T., Tolba, M. F., Trivedi, R., Tadros, M. G., Arafa, H. M. M., & Abdel‐Naim, A. B. (2016) · PeerJ · doi:10.7717/peerj.2168 · Cited by 14
Glycoconjugated Site-Selective DNA-Methylating Agent Targeting Glucose Transporters on Glioma Cells
Buchanan, M. K., Needham, C. N., Neill, N. E., White, M. C., Kelly, C. B., Mastro-Kishton, K., Chauvignè-Hines, L. M., Goodwin, T. J., McIver, A. L., Bartolotti, L. J., et al. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b01075 · Cited by 13
Internal Targeting and External Control: Phototriggered Targeting in Nanomedicine
Arrué, L., & Ratjen, L. (2017) · ChemMedChem · doi:10.1002/cmdc.201700621 · Cited by 15
Миронов, А. Ф., Ostroverkhov, P. V., Tikhonov, S. I., Pogorilyy, V., Kirin, N. S., Chudakova, O. O., Tsygankov, A. A., & Grin, M. A. (2021) · Fine Chemical Technologies · doi:10.32362/2410-6593-2020-15-6-16-33 · Cited by 13
Sharma, S., Agnihotri, N., Kumar, K., Sihag, S., Randhawa, V., Kaur, R., Singh, R., & Kaur, V. (2021) · Applied Organometallic Chemistry · doi:10.1002/aoc.6521 · Cited by 13
Raju, S., Sheridan, P. E., Hauer, A. K., Garrett, A. E., McConnell, D. E., Thornton, J. A., Stokes, S. L., & Emerson, J. P. (2022) · Chemistry & Biodiversity · doi:10.1002/cbdv.202200327 · Cited by 12
Carbohydrate–macrocycle conjugates for biomedical applications
Yin, F., Li, J., Shi, B.-S., Zhang, K., Li, X., Wang, K., & Guo, D. (2023) · Materials Chemistry Frontiers · doi:10.1039/d3qm00540b · Cited by 13
Tiwari, G., Khanna, A., Tyagi, R., Mishra, V. K., Narayana, C., & Sagar, R. (2024) · Scientific Reports · doi:10.1038/s41598-023-50202-4 · Cited by 15
“Thus, adding the pharmacophoric moiety ( N -heterocycles) with the glycone unit has become an effective tool for the medication of rapidly growing cancerous cells 39,40 .”
Domińska, M., Pastuch-Gawołek, G., Domiński, A., Kurcok, P., & Erfurt, K. (2022) · Molecules · doi:10.3390/molecules27031040 · Cited by 12
How Nanotechniques Could Vitalize the O-GlcNAcylation-Targeting Approach for Cancer Therapy
Yang, R., Wang, L., Wu, Z., Yin, Y., & Jiang, S. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s360488 · Cited by 12
“Glycoconjugated drugs are being experimented for improved selectivity in cancer targeting.(32) These “passive” targeting features of nanocarriers have been successfully used to enhance the drug accumulation in cancer tissues and alleviate the side effects.”
BackgroundHolzer, I., Desiatkina, O., Anghel, N., Johns, S. K., Boubaker, G., Hemphill, A. F., Furrer, J., & Păunescu, E. (2023) · Molecules · doi:10.3390/molecules28020902 · Cited by 12
“The cancer cells glucose metabolism can be exploited for targeted therapy [56], and consequently, glycoconjugates of various metal complexes were explicitly designed for selective uptake by cells overexpressing glucose transporters [57–59].”
BackgroundTabakmakher, K. M., Makarieva, T. N., Денисенко, В. А., Popov, R. S., Dmitrenok, P. S., Dyshlovoy, S. A., Grebnev, B. B., Bokemeyer, C., Amsberg, G. V., & Cường, N. X. (2019) · Marine Drugs · doi:10.3390/md17080445 · Cited by 12
“Cancer cells are characterized by increased glucose consumption, which is related to their rapid growth and metabolism [37].”
BackgroundMeng, X., Lian, X., Li, X., Ya, Q., Li, T., Zhang, Y., Yang, Y., & Zhang, Y. (2020) · Carbohydrate Research · doi:10.1016/j.carres.2020.108034 · Cited by 12
Design of Evodiamine–Glucose Conjugates with Improved In Vivo Antitumor Activity
Wu, Z., Chen, S., Chen, Z., Dong, G., Xu, D., & Sheng, C. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00221 · Cited by 11
Arévalo‐Ruiz, M., Amrane, S., Rosu, F., Belmonte‐Reche, E., Peñalver, P., Mergny, J., & Morales, J. C. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103786 · Cited by 11
Kleczewska, N., Sikorski, P. J., Warminska, Z., Markiewicz, Ł., Kasprzyk, R., Baran, N., Kwapiszewska, K., Karpińska, A., Michalski, J., Hołyst, R., et al. (2021) · Chemical Science · doi:10.1039/d1sc02143e · Cited by 11
Nuttall, R. E., Pham, T., Chadwick, A. C., Hungnes, I. N., Firth, G., Heckenast, M. A., Sparkes, H. A., Galán, M. C., Ma, M., & Pringle, P. G. (2023) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.2c04008 · Cited by 11
“39 The radioactive 18 F-labeled glucose derivative, [ 18 F]- FDG ([ 18 F]-2-fluoro-2-deoxyglucose), is taken up by the GLUT1 transporter which is overexpressed in cancer, and [ 18 F]-FDG is routinely used as a diagnostic PET imaging agent in oncology.”
MethodSmall Molecule and Peptide Recognition of Protein Transmembrane Domains
Zeng, X., Wu, P., Yao, C., Liang, J., Zhang, S., & Yin, H. H. (2017) · Biochemistry · doi:10.1021/acs.biochem.6b00909 · Cited by 11
Badhani, B., & Kakkar, R. (2017) · Structural Chemistry · doi:10.1007/s11224-017-1068-y · Cited by 11
New desulfured troglitazone derivatives: Improved synthesis and biological evaluation
Dupommier, D., Muller, C., Comoy, C., Mazerbourg, S., Bordessa, A., Piquard, E., Pawlak, M., Piquard, F., Martin, H., de Fays, E., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111939 · Cited by 13
“Numerous examples of this strategy have been reported [28].”
BackgroundCharacterization of a near-infrared fluorescent DCPO-tagged glucose analogue for cancer cell imaging
Fang, Y., Zhang, W., Zhu, M., Chen, S., Liu, X., Lu, W. P., & Zhang, X. (2016) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2016.11.021 · Cited by 11
“Moreover, phloretin has been demonstrated to be an effective inhibitor of GLUT-1 [21], so we further determined the effect of phloretin on N2 uptake.”
Vorčáková, K., Májeková, M., Horáková, E., Drabina, P., Sedlák, M., & Štěpánková, Š. (2018) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.03.012 · Cited by 12
Cyclam glycoconjugates as lectin ligands and protective agents of metal-induced amyloid aggregation
Lanza, V., D’Agata, R., Iacono, G., Bellia, F., Spoto, G., & Vecchio, G. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2015.06.016 · Cited by 11
Recent Advances in the Development of Metal-Glycoconjugates for Medicinal Applications
Brescia, F., Titilas, I., Cacciapuoti, S., & Ronconi, L. (2025) · Molecules · doi:10.3390/molecules30173537 · Cited by 14
“…a sugar ( e.g., glucose, 2-deoxyglucose, galactose, mannose, glucosamine) into the formulation of a bioactive metal complex would make the overall metal-glycoconjugate recognizable by, and possibly preferentially internalized through, such transporters overexpressed in tumor cells [37].”
de la Torre‐Rubio, E., Muñoz‐Moreno, L., Bajo, A. M., Arias, M. S., Cuenca, T., Gude, L., & Royo, E. (2023) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2023.112326 · Cited by 10
Glycated nisin enhances nisin's cytotoxic effects on breast cancer cells
Mohammadi, A., Kazemipour, N., Ghorbankhani, G. A., Morovati, S., & Sadeghian, M. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-68765-1 · Cited by 14
Kazemi, Z., Moini, N., Rudbari, H. A., & Micale, N. (2024) · Medicinal Research Reviews · doi:10.1002/med.22083 · Cited by 12
Wen, Z., Pramanik, A., Lewicki, S. A., Jung, K., Gao, Z.-G., Randle, J. C. R., Breton, S., Chen, Z., Whitehead, G. S., Salvemini, D., et al. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00489 · Cited by 10
Shafi, S., Khan, M. A., Ahmad, J., Rabbani, S. A., Singh, S., & Najmi, A. K. (2024) · Current Drug Targets · doi:10.2174/0113894501335877240926101134 · Cited by 10
On‐Membrane Supramolecular Assemblies Serving as Bioorthogonal Gating for Melphalan
Xu, H., Yao, Q., Hu, X., Zheng, D., Ren, C., Ren, Z., & Gao, Y. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202502922 · Cited by 10
Insights into the effect of sertraline on anaerobic digestion: Stimulating CH4 and CO2 production
He, D., Zheng, S., Ye, Y., Xiang, J., Duan, A., Xiao, J., & Wang, D. (2025) · Water Research · doi:10.1016/j.watres.2025.124166 · Cited by 10
Influences of galactose ligand on the uptake of TADF liposomes by HepG2 cells
Wang, C., Chen, Z., Tang, X., Li, L., Wang, N., Li, W., & Liu, T. (2020) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2020.102014 · Cited by 10
Carbohydrate-based inducers of cellular stress for targeting cancer cells
Ndombera, F. T., VanHecke, G. C., Nagi, S., & Ahn, Y. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.01.063 · Cited by 10
Glycoconjugation as a Promising Treatment Strategy for Psoriasis
Makuch, S., Woźniak, M., Krawczyk, M., Pastuch-Gawołek, G., Szeja, W., & Agrawal, S. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.263657 · Cited by 11
“The design of specific targeting ligands has been presented in several excellent review publications (Calvaresi and Hergenrother, 2013; Granchi et al., 2016),”
BackgroundSun, B., Mullapudi, S. S., Zhang, Y., & Neoh, K. G. (2022) · Microchimica Acta · doi:10.1007/s00604-022-05411-5 · Cited by 10
“GLUTs are responsible for the transport of glucose across the cell membrane and their overexpression on most cancer cells including NMIBC has been reported [19, 20].”
BackgroundInfluentialYang, C., Xia, A., Du, C., Hu, M., Gong, Y., Tian, R., Jiang, X., & Xie, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1014854 · Cited by 10
“Therefore, the overexpression of GLUTs in tumor cells provides a new strategy for improving the selectivity of chemotherapy drugs by conjugating cytotoxic drugs to glucose (Calvaresi and Hergenrother, 2013).”
BackgroundShang, W., Hu, Y., He, Y., Niu, D., & Li, W. (2025) · Science Advances · doi:10.1126/sciadv.ady2175 · Cited by 9
“Sugar conjugation has emerged as a valuable strategy to improve the pharmacokinetic profiles of drug candidates ( 72 , 73 ).”
Cybulski, M., Sidoryk, K., Zaremba-Czogalla, M., Trzaskowski, B., Kubiszewski, M., Tobiasz, J., Jaromin, A., & Michalak, O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052573 · Cited by 10
Tunable GLUT–Hexose Binding and Transport via Modulation of Hexose C‐3 Hydrogen‐Bonding Capabilities
Kondapi, V. P. K., Soueidan, M., Cheeseman, C. I., & West, F. G. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201701329 · Cited by 10
Anti-cancer agents and reactive oxygen species modulators that target cancer cell metabolism
Ndombera, F. T. (2017) · Pure and Applied Chemistry · doi:10.1515/pac-2016-1219 · Cited by 9
Syntheses of two kinds of disaccharide subunits of antitumor antibiotic bleomycins
Che, R., Zhu, Q., Yu, J., Li, J., Yu, J., & Lu, W. P. (2017) · Tetrahedron · doi:10.1016/j.tet.2017.09.009 · Cited by 9
Near-infrared fluorescent sorbitol probe for tumor diagnosis in vivo
Lee, S., Lim, W., Jo, D., Jung, J. S., Kim, S., Jo, G., Min, J., Choi, E. Y., & Hyun, H. (2018) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2018.02.004 · Cited by 9
Schoch, S., Iacopini, D., Pozza, M. D., Pietro, S. D., Degano, I., Gasser, G., Bussolo, V. D., & Marchetti, F. (2022) · Organometallics · doi:10.1021/acs.organomet.1c00519 · Cited by 9
Zhang, J., Hughes, R. R., Saunders, M. A., Elshahawi, S. I., Ponomareva, L. V., Zhang, Y., Winchester, S. R., Scott, S. A., Sunkara, M., Morris, A. J., et al. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.6b00949 · Cited by 10
Glucose-derived carbon dots for targeted delivery of doxorubicin in cancer therapy
Dubey, N., Ramteke, S., Jain, N. K., Dutta, T., & Koner, A. L. (2023) · New Journal of Chemistry · doi:10.1039/d3nj02843g · Cited by 9
Jung, Y., Choi, J. S., Ryu, J.-Y., Zhang, Z., & Lim, Y. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.3c05638 · Cited by 10
Du, Z., Li, G., Zhou, X., & Zhang, J. (2021) · Molecules · doi:10.3390/molecules26030772 · Cited by 8
“Some anticancer drugs including azomycin, adriamy‐ cin and paclitaxel, can be specifically delivered to cancer cells by covalently conjugating them with carbohydrates [3].”
Horáková, E., Drabina, P., Brož, B., Štěpánková, Š., Vorčáková, K., Královec, K., Havelek, R., & Sedlák, M. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2016.1212193 · Cited by 10
New Research in Ionizing Radiation and Nanoparticles: The ARGENT Project
Ferruz, M. B., Ivošev, V., Haume, K., Ellis-Gibbings, L., Traore, A., Thakare, V., Rosa, S., de Vera, P., Tran, V. L., Mika, A., et al. (2016) · Springer eBooks · doi:10.1007/978-3-319-43030-0_12 · Cited by 8
ATP and NADPH coated iron oxide nanoparticles for targeting of highly metabolic tumor cells
Bonvin, D., Bastiaansen, J., Stuber, M., Hofmann, H., & Ebersold, M. M. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01935a · Cited by 8
Therapeutic applications of carbohydrate-based compounds: a sweet solution for medical advancement
Lalhmangaihzuala, S., Vanlaldinpuia, K., Khiangte, V., Laldinpuii, Z., liana, T., Lalhriatpuia, C., & Pachuau, Z. (2024) · Molecular Diversity · doi:10.1007/s11030-024-10810-2 · Cited by 15
“…compounds can be easily incorporated with various supports such as nanoparticles, metal complexes, and homo-or heteroaromatic compounds to exert a significant cytotoxic effect against numerous cancer cell lines while exhibiting a less toxic effect on normal healthy cells [14, 18, 94, 95].”
Iorio, A. L., Lenci, E., Marzano, C., Bucaletti, E., Tirinnanzi, B., Casati, G., Giunti, L., Dallari, C., Credi, C., Sardi, I., et al. (2024) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.4c00398 · Cited by 7
Verma, N., Tiwari, G., Khanna, A., Mishra, V. K., Yadav, Y., Malviya, M., & Sagar, R. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108161 · Cited by 7
Chen, S., Kwek, K.-K., Lee, Z. H., & Lin, H. (2025) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2025.113290 · Cited by 7
Direct deoxygenative arylation of saccharides via phosphorus-assisted C−OH bond activation
Ye, X.-Y., Huang, S., Guo, S., Wang, G., Lv, W., & Chi, Y. R. (2025) · Nature Communications · doi:10.1038/s41467-025-67061-4 · Cited by 7
Confalonieri, L., Imperio, D., Erhard, A., Fallarini, S., Compostella, F., Grosso, E. D., Balcerzyk, M., & Panza, L. (2022) · ACS Omega · doi:10.1021/acsomega.2c06551 · Cited by 7
Behar, A. E., & Maayan, G. (2023) · Antioxidants · doi:10.3390/antiox12122031 · Cited by 8
Small-molecule inhibitors of glucose transporters
Kawatani, M., & Osada, H. (2024) · Vitamins and hormones · doi:10.1016/bs.vh.2024.06.001 · Cited by 7
Sharma, S. K., & Sagar, R. (2025) · Carbohydrate Research · doi:10.1016/j.carres.2025.109395 · Cited by 7
Wang, D., Liu, X., Zhang, X., Pham, T. T., Zhuang, J., Li, B., Chong, K. C., Liu, C., Shan, Y., Wu, M., et al. (2025) · Advanced Materials · doi:10.1002/adma.202505726 · Cited by 7
Ghosh, S., Paul, S., Ghosh, S., Mukherjee, S., De, P., Das, R., & Mukherjee, A. (2025) · Small · doi:10.1002/smll.202505316 · Cited by 7
OleD Loki as a Catalyst for Tertiary Amine and Hydroxamate Glycosylation
Hughes, R. R., Shaaban, K. A., Zhang, J., Cao, H., Phillips, G. N., & Thorson, J. S. (2017) · ChemBioChem · doi:10.1002/cbic.201600676 · Cited by 7
OleD Loki as a Catalyst for Hydroxamate Glycosylation
Hughes, R. R., Shaaban, K. A., Ponomareva, L. V., Horn, J., Zhang, C., Zhan, C., Voss, S. R., Leggas, M. L., & Thorson, J. S. (2019) · ChemBioChem · doi:10.1002/cbic.201900601 · Cited by 8
Zuccolo, M., Arrighetti, N., Perego, P., & Colombo, D. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210806110857 · Cited by 8
Song, K., Nimse, S. B., Kim, J., Warkad, S. D., & Kim, T. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00646 · Cited by 7
Alkhodier, R. A., Mishra, S. K., Doerksen, R. J., & Colby, D. A. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c01147 · Cited by 7
Amino-OPE glycosides and blue light: a powerful synergy in photodynamic therapy
Lara-Pardo, A., Mancuso, A., Simón‐Fuente, S., Bonaccorsi, P. M., Gangemi, C. M. A., Molina, M. Á., Puntoriero, F., Ribagorda, M., Barattucci, A., & Sanz-Rodrı́guez, F. (2022) · Organic & Biomolecular Chemistry · doi:10.1039/d2ob01742c · Cited by 7
Panebianco, R., Viale, M., Loiacono, F., Lanza, V., Milardi, D., & Vecchio, G. (2023) · ChemMedChem · doi:10.1002/cmdc.202200701 · Cited by 7
Bandaru, S., Palanivel, M., Ravipati, M., Wu, W., Zahid, S., Halkarni, S. S., Dalapati, G. K., Ghosh, K. K., Gulyás, B. Z., Padmanabhan, P., et al. (2024) · ACS Omega · doi:10.1021/acsomega.3c04962 · Cited by 7
Lameijer, L. N., le Roy, J., van der Vorm, S., & Bonnet, S. A. (2018) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.8b01342 · Cited by 7
Novel target NIR-fluorescent polymer for living tumor cell imaging
Zhao, Y., Wu, Y. Q., Bai, X., Jin, X., & Zhu, X. (2018) · Polymer Chemistry · doi:10.1039/c8py01442f · Cited by 8
Cell line studies and analytical measurements of three paclitaxel complex variations
Manning, T. J., Plummer, S., Woods, R., Wylie, G., Phillips, D. R., & Krajewski, L. C. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.04.070 · Cited by 8
Insulin and novel thioglycosides exert suppressive effect on human breast and colon carcinoma cells
Agrawal, S., Woźniak, M., Łuc, M., Walaszek, K., Pielka, E., Szeja, W., Pastuch-Gawołek, G., Gamian, A., & Ziolkowski, P. P. (2017) · Oncotarget · doi:10.18632/oncotarget.23170 · Cited by 10
“The field of synthesis and evaluation of sugar-conjugated anticancer agents has grown significantly in recent years, with certain compounds in advanced clinical trials [1].”
BackgroundXiong, J., Yeung, K., Wong, C. T. T., Fong, W., & Ng, D. K. P. (2022) · Colorants · doi:10.3390/colorants1020012 · Cited by 6
Antitumor effects of new glycoconjugated Pt II agents dual-targeting GLUT1 and Pgp proteins
Zhang, Q., Shao, J., Wang, J., Gong, X., Liu, W., Wang, S., Zhang, Y., Yang, S., Zhang, Q., Wei, J., et al. (2022) · Dalton Transactions · doi:10.1039/d2dt02455a · Cited by 6
Hilali, M. E., Reux, B., Débiton, E., Leal, F., Galmier, M., Vivier, M., Chezal, J., Miot-Noirault, E., Coudert, P., & Weber, V. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.08.043 · Cited by 7
Synthesis and Biological Evaluation of New Glycoconjugated LDH Inhibitors as Anticancer Agents
D’Andrea, F., Vagelli, G., Granchi, C., Guazzelli, L., Tuccinardi, T., Poli, G., Iacopini, D., Minutolo, F., & Bussolo, V. D. (2019) · Molecules · doi:10.3390/molecules24193520 · Cited by 6
“Furthermore, the consequential overexpression of glucose transporters (GLUTs) in the membrane of cancer cells can be either targeted by modulators of the carbohydrate flux through these proteins [5] or exploited for the preferential intracellular accumulation of glycoconjugates containing cytotoxic drugs [6].”
Luteolin Induces Selective Cell Death of Human Pluripotent Stem Cells
Go, Y.-H., Kim, J., Jeong, H., Kim, S.-M., Kim, Y.-J., Park, S., Moon, S.-H., & Cha, H. (2020) · Biomedicines · doi:10.3390/biomedicines8110453 · Cited by 6
“As the conjugation of glucose to drug molecules has been widely applied to improve the delivery of drugs to brains [28,29] or cancers [30,31] with high expression of glucose transporters, quercetin glycoside (QC-GLU) may have more potent stemotoxic properties against undifferentiated hPSCs than QC.”
BackgroundComputer-aided design of glucoside brain-targeted molecules based on 4PYP
Tian, Y., Shen, S., Gu, L., Zhou, J., Li, Y., & Zheng, X. (2020) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2020.107819 · Cited by 6
Peptide‐Coated Platinum Nanoparticles with Selective Toxicity against Liver Cancer Cells
Shoshan, M. S., Vonderach, T., Hattendorf, B., & Wennemers, H. (2018) · Angewandte Chemie · doi:10.1002/ange.201813149 · Cited by 5
Single-cell RNA sequencing depicts metabolic changes in children with aplastic anemia
Zhou, Q., Huang, L., Liu, Y., Huang, J., Wen, L., Yang, J., Liang, J., Chen, Y., & Chen, C. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1075408 · Cited by 7
“In order to promote drug uptake and enhance the delivery ability to target T-cell populations, we coupled them with glucose transporters (20).”
BackgroundSahoo, S., Pathak, S., Kumar, A., Nandi, D., & Chakravarty, A. R. (2023) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2023.112226 · Cited by 5
Pokhilo, N. D., Денисенко, В. А., & Ануфриев, В. Ф. (2014) · Russian Journal of Organic Chemistry · doi:10.1134/s1070428014050054 · Cited by 5
Wang, Z., Liu, R., Zhang, X., Chang, X., Gao, M., Zhang, S., Guan, Q., Sun, J. F., Zuo, D., & Zhang, W. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116671 · Cited by 6
Krajnakova, L., Pisarčíková, J., Drajna, L., Labudová, M., Imrich, J., Paulíková, H., & Kožurková, M. (2018) · Medicinal Chemistry Research · doi:10.1007/s00044-018-2241-6 · Cited by 5
“The studies confirmed that one group of these glyco-acridine conjugates could prevent amyloid fibrillization, but the cytotoxicity of the derivatives and their effect on AChE was not part of the scope of this research (Calvaresi and Hergenrother 2013).”
BackgroundPriyanka, K., & Singh, S. K. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.05.002 · Cited by 6
Fluctuation Spectroscopy Analysis of Glucose Capped Gold Nanoparticles
Porcaro, F., Miao, Y., Kota, R., Haun, J. B., Polzonetti, G., Battocchio, C., & Gratton, E. (2016) · Langmuir · doi:10.1021/acs.langmuir.6b02545 · Cited by 5
Merk, D., & Schubert-Zsilavecz, M. (2017) · Methods and principles in medicinal chemistry · doi:10.1002/9783527674381.ch8 · Cited by 3
Access to Thioglycoconjugate Bioorganometallic Ferrocenes via a Copper-Catalyzed Coupling
Rhaz, A. E., Messé, E., Retailleau, P., Erb, W., Messaoudi, S., & Bideau, F. L. (2025) · Organic Letters · doi:10.1021/acs.orglett.5c02292 · Cited by 4
Pastuch-Gawołek, G., & Szreder, J. (2025) · Molecules · doi:10.3390/molecules30020427 · Cited by 4
“The glycoconjugation of quinoline derivatives aimed to enhance the selectivity of the resulting compounds by leveraging differences in metabolic pathways of cancer cells compared to healthy cells, specifically their increased demand for D-glucose [50,51].”
Synthesis of a glucose conjugate of pristimerin and evaluation of its anticancer activity
Yang, F., Zhang, J., Li, J., Ye, W., Li, A., & He, W. (2022) · Chinese Chemical Letters · doi:10.1016/j.cclet.2022.04.036 · Cited by 4
Sequence-controlled glycooligomers for tumor targeting
Chen, J., Zhang, Y., Gao, Q., Wang, W. J., Zhu, L., Khedr, G. E., Xing, Q., Shi, W., & Geng, J. (2023) · Cell Reports Physical Science · doi:10.1016/j.xcrp.2023.101749 · Cited by 5
Voelcker, G. (2019) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000782 · Cited by 4
A phenanthroindolizidine glycoside with HIF-1 inhibitory activity from Tylophora atrofolliculata
Chen, C., Zhu, G., Xie, T.-G., Jiang, P.-C., Wang, J., & Jiang, Z. (2019) · Phytochemistry Letters · doi:10.1016/j.phytol.2019.03.003 · Cited by 4
Drug Delivery Applications of Peptide Materials
Hamsici, S., Gunay, G., Kirit, H. A., Kamatar, A., Loving, K., & Acar, H. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839161148-00291 · Cited by 4
Jabbari, H., Khosravi, S., & Azimi, S. (2022) · The Open Medicinal Chemistry Journal · doi:10.2174/18741045-v16-e2209140 · Cited by 4
Pyrimidine-derived disulfides as potential antimicrobial agents: synthesis and evaluation in vitro
Bonaccorsi, P. M., Barattucci, A., Papalia, T., Criseo, G., Faggio, C., & Romeo, O. (2015) · Journal of Sulfur Chemistry · doi:10.1080/17415993.2015.1024679 · Cited by 4
“Thiocytosine glucosides 2 and 3 are part of a project in which we intended to prepare small glucosides to be tested as antimicrobial and/or anticancer therapeutics.[16] However, they are inactive against all the bacteria and fungi tested in this study, together with thiocytosine (1).”
BackgroundPatkulkar, P. A., Arjun, S. V., Sharma, A., Panda, S. K., Vinay, V., Shringi, C., & Sinharay, S. (2025) · JACS Au · doi:10.1021/jacsau.5c00151 · Cited by 3
Metadata
- Authors
- Calvaresi, E. C., & Hergenrother, P. J.
- Affiliations
- University of Illinois Urbana-Champaign (US)
- Corresponding author
- Hergenrother, Paul J.
- Venue
- Chemical Science
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2013
- Volume
- 4
- Issue
- 6
- Pages
- 2319
- ISSN
- 2041-6520 (ISSN-L)
- 2041-6539
- PMC
- PMC3784344
- OpenAlex
- W2110592482
- Cited by
- 398
- References
- 98
- Citations by year
- 2026: 16 · 2025: 42 · 2024: 29 · 2023: 32 · 2022: 41 · 2021: 24 · 2020: 42 · 2019: 43 · 2018: 32 · 2017: 28 · 2016: 40 · 2015: 17 · 2014: 10 · 2013: 2
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Chemical Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- U.S. Food and Drug Administration
- University of Illinois at Urbana-Champaign
- National Cancer Institute (F30CA168323)
- National Institute of General Medical Sciences (R01GM098453)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- glycoconjugates, glucose conjugation, tumor targeting, Warburg effect, aerobic glycolysis, cytotoxin, cancer metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.